Impact of a Self-rehabilitation and Tele-rehabilitation Program on the Post-stroke Care Pathway

Launched by ASSOCIATION APPROCHE · May 30, 2024

Keywords

ClinConnect Summary

This clinical trial, called the AutonHome® study, is investigating how a new self-rehabilitation and tele-rehabilitation program can help patients recover after having a stroke. The study looks at two types of strokes: hemorrhagic and ischemic. It aims to find out if using a special device, called AutonHome®, along with regular rehabilitation can improve recovery for stroke patients. This device allows patients to follow personalized rehabilitation exercises at home, guided by their therapist, which means they won’t need to travel to a clinic as often. The goal is to show that this combination of self-care and traditional therapy helps patients recover better and faster.

To participate in this study, individuals must be between the ages of 18 and 85 and have had a recent stroke within the last 30 days. They should also show certain levels of physical ability and cognitive function. Participants will be divided into two groups: one will receive standard rehabilitation at a center, while the other will use the AutonHome® device along with their standard care. The study will last for 15 weeks, and participants can expect to contribute to important research that could improve stroke recovery methods for many people in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants who signed the written consent form to participate in the study after free and informed information
• • Participants affiliated to a social security scheme (beneficiary or beneficiary) outside the AME.
• • 18 years ≤ age ≤ 85 years,
• • 1st recent ischemic or hemorrhagic unilateral cortico-subcortical hemispheric stroke
• • Minimum post-stroke delay: 7 days
• • Maximum post-stroke delay : 30 days
• • SOFMER category 2: moderate strokes called category 2 according to SOFMER with an NIHSS (initial score of the National Institute of Health Stroke Scale) between 5 and 14 (Several deficiencies or motor deficit of the lower limb prohibiting walking, with recovery potential, a probable autonomy project (unilateral stroke).
• • MoCA \> 23
• Exclusion Criteria:
• • Participant deprived of liberty (by judicial or administrative decision)
• • Adult participant subject to a legal protection measure or unable to express their consent
• • Participation in another ongoing clinical trial
• • Pregnant or breastfeeding women or women of childbearing age without effective contraception
• • Lack of command of the oral and written French language
• • Pre-existing neurological pathology
• • Severe expression disorders (expression aphasia) affecting intelligibility
• • Severe comprehension disorders (comprehension aphasia)
• • Major cognitive disorders of the dementia or post-dementia type
• • Unstable psychiatric disorders
• • Unstabilized medical pathology
• • Unbalanced epilepsy
• • Color blindness